These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19149719)

  • 1. Therapeutic antibodies and other proteins obtained by molecular display technologies.
    Shibasaki S; Ueda M
    Recent Pat Biotechnol; 2009; 3(1):19-27. PubMed ID: 19149719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phage display derived therapeutic antibodies.
    Thie H; Meyer T; Schirrmann T; Hust M; Dübel S
    Curr Pharm Biotechnol; 2008 Dec; 9(6):439-46. PubMed ID: 19075684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biotechnology and applications of antibody engineering.
    Rapley R
    Mol Biotechnol; 1995 Apr; 3(2):139-54. PubMed ID: 7620975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rapid discovery of engineered antibodies.
    Wang M; He M
    IDrugs; 2007 Aug; 10(8):562-5. PubMed ID: 17665332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Antibody Engineering and Selection Strategies.
    Ministro J; Manuel AM; Goncalves J
    Adv Biochem Eng Biotechnol; 2020; 171():55-86. PubMed ID: 31776591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant antibodies as therapeutic agents: pathways for modeling new biodrugs.
    Aires da Silva F; Corte-Real S; Goncalves J
    BioDrugs; 2008; 22(5):301-14. PubMed ID: 18778112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage display technology: clinical applications and recent innovations.
    Azzazy HM; Highsmith WE
    Clin Biochem; 2002 Sep; 35(6):425-45. PubMed ID: 12413604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and production of commercial therapeutic monoclonal antibodies in Mammalian cell expression systems: an overview of the current upstream technologies.
    Chartrain M; Chu L
    Curr Pharm Biotechnol; 2008 Dec; 9(6):447-67. PubMed ID: 19075685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies: technologies for early discovery and engineering.
    Kennedy PJ; Oliveira C; Granja PL; Sarmento B
    Crit Rev Biotechnol; 2018 May; 38(3):394-408. PubMed ID: 28789584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging trends in the synthesis and improvement of hapten-specific recombinant antibodies.
    Yau KY; Lee H; Hall JC
    Biotechnol Adv; 2003 Oct; 21(7):599-637. PubMed ID: 14516873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond natural antibodies: the power of in vitro display technologies.
    Bradbury AR; Sidhu S; Dübel S; McCafferty J
    Nat Biotechnol; 2011 Mar; 29(3):245-54. PubMed ID: 21390033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering antibodies by yeast display.
    Boder ET; Raeeszadeh-Sarmazdeh M; Price JV
    Arch Biochem Biophys; 2012 Oct; 526(2):99-106. PubMed ID: 22450168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of yeast molecular display systems focused on therapeutic proteins, enzymes, and foods: functional analysis of proteins and its application to bioconversion.
    Shibasaki S; Ueda M
    Recent Pat Biotechnol; 2010 Nov; 4(3):198-213. PubMed ID: 21171957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monoclonal antibodies, 30 years of success].
    Laffly E; Sodoyer R
    J Soc Biol; 2006; 200(4):325-43. PubMed ID: 17652969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant antibodies for cancer diagnosis and therapy.
    Hudson PJ; Souriau C
    Expert Opin Biol Ther; 2001 Sep; 1(5):845-55. PubMed ID: 11728219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody phage display: overview of a powerful technology that has quickly translated to the clinic.
    Kotlan B; Glassy MC
    Methods Mol Biol; 2009; 562():1-15. PubMed ID: 19554283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Historical development of monoclonal antibody therapeutics.
    Nissim A; Chernajovsky Y
    Handb Exp Pharmacol; 2008; (181):3-18. PubMed ID: 18071939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agrobacterium-mediated transient expression as an approach to production of recombinant proteins in plants.
    Sheludko YV
    Recent Pat Biotechnol; 2008; 2(3):198-208. PubMed ID: 19075868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered proteins as specific binding reagents.
    Binz HK; Plückthun A
    Curr Opin Biotechnol; 2005 Aug; 16(4):459-69. PubMed ID: 16005204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.